Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAP and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function

NCT00117416 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT00117416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00117416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAP and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function
Lead sponsor
University Hospital, Ghent
Phase
Not applicable
Overall status
Withdrawn
Start date
February 28, 2003
Completion date
February 28, 2003
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure, acute